MiR-3175 promotes epithelial-mesenchymal transition by targeting Smad7 in human conjunctiva and pterygium

Area of Science:

• Ophthalmology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) regulate gene expression post-transcriptionally.
• The role of miRNAs in pterygium, an ocular surface disease involving fibrovascular proliferation and invasion, remains unclear.
• MiR-3175 is found at higher levels in pterygium tissues than in normal conjunctiva.

Purpose of the Study:

• To investigate the function of MiR-3175 in the epithelial-mesenchymal transition (EMT) of pterygium.
• To elucidate the molecular mechanism by which MiR-3175 influences pterygium pathogenesis.
• To validate findings in both cell culture and patient-derived pterygium tissues.

Main Methods:

• Utilized a cultured human conjunctival epithelium cell line (CCL) to study MiR-3175's effects.
• Assessed cell proliferation, migration, and invasion in response to MiR-3175.
• Investigated the direct inhibition of Smad7 by MiR-3175.
• Validated findings in pterygium tissues from patients.

Main Results:

• MiR-3175 significantly promotes proliferation, migration, and invasion of CCL cells.
• MiR-3175 directly inhibits the expression of Smad7.
• The observed effects on cell behavior are mediated through the inhibition of Smad7.

Conclusions:

• The MiR-3175-Smad7 axis plays a critical role in the pathogenesis and development of pterygium.
• MiR-3175 acts as a pro-EMT factor in pterygium.
• Targeting the MiR-3175-Smad7 pathway may offer therapeutic strategies for pterygium.